THE USE OF XANTINE DERIVATIVES FOR PROMOTION OF HEALING OF OPERATIVE LESIONS
The invention relates to the use of 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione (generic name: pentoxifylline) and/or 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium theophylline-7-acetate (Depogen) or monohydrate thereof for preparing a pharmaceutical compo...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
27.04.1995
|
Edition | 5 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to the use of 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione (generic name: pentoxifylline) and/or 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium theophylline-7-acetate (Depogen) or monohydrate thereof for preparing a pharmaceutical composition suitable for improving the tissue antioxidant status. This status plays an important role in complications, occurring as a consequence of pathologically developed or artificially established anastomoses, particularly anastomosis of oesophagus and colon since these organs possess a very weak antioxidant protective system. The invention furthermore relates to the preparation of the above pharmaceutical compositions. The above active ingredients promote and accelerate the healing process of anastomoses by improving the tissue antioxidant status and besides, they retain their good inhibitory effect on the adhesion of anastomoses. |
---|---|
Bibliography: | Application Number: HU19930002229 |